Search

Your search keyword '"Berghea, Florian"' showing total 122 results

Search Constraints

Start Over You searched for: Author "Berghea, Florian" Remove constraint Author: "Berghea, Florian"
122 results on '"Berghea, Florian"'

Search Results

1. Calcinosis in Rheumatic Disease Is Still an Unmet Need: A Retrospective Single-Center Study

7. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

10. Do We Have Good Activity Indices in Systemic Sclerosis?

14. Differences and similarities in rheumatology specialty training programmes across European countries

15. Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-project

16. Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to countryʼs wealth?

17. Inequities in access to biologic and synthetic DMARDs across 46 European countries

18. EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries

20. Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries

21. AB0658 ROLE OF NAILFOLD CAPILLAROSCOPY IN MONITORING LUNG INVOLVEMENT OF SYSTEMIC SCLEROSIS

22. FRI0324 DISEASE ACTIVITY INDICES IN SYSTEMIC SCLEROSIS- WHICH TO USE IN DAILY PRACTICE?

23. Considerations for Evaluating and Recommending Worker Productivity Outcome Measures: An Update from the OMERACT Worker Productivity Group

26. Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

27. Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists

28. Original papers: clinical or basic research anti-cyclic citrullinated peptide antibodies - activity markers in rheumatoid arthritis

29. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

30. Quantitative Doppler in musculoskeletal ultrasonography – suboptimal performance of both experienced and in-training sonographers in selection of the highest Doppler signal image from cine-loops

32. Low vitamin D status in systemic sclerosis and the impact on disease phenotype

34. Annals of the Rheumatic Diseases. The Eular Journal / Development of Patient-centred Standards of Care for Osteoarthritis in Europe: the eumusc.net-project

35. Testarea anticorpilor ANA la rudele de gradul întâi ale pacienţilor cu lupus eritematos sistemic (LES).

37. TARGETING INTERLEUKIN 17 IN THE TREATMENT OF RHEUMATOID ARTHRITIS.

38. FINANCIAL CONSTRAINS IN THE HEALTH SECTOR: ROMANIAN PLACE IN EUROPEAN PERSPECTIVE WITH A FOCUS ON RHEUMATIC DISEASE.

39. TRIGGER FINGER - SONOGRAPHIC DIAGNOSTIC AND THERAPEUTIC APPROACH.

41. Clinical Phenotype of Endothelial Dysfunction in Romanian Scleroderma Patients.

42. Clinical Phenotype of Endothelial Dysfunction in a Lot of Romanian Scleroderma Patients.

46. STATUSUL VITAMINEI D ŞI CORELAȚII CLINICO-BIOLOGICE LA UN LOT DE PACIENȚI CU SCLEROZĂ SISTEMICĂ.

47. “50 shades of groin pain” in an unusual case of osteomyelitis pubis following surgery .

48. Education in musculoskeletal ultrasonography: training in interventional procedures on a swine model.

49. IMMUNOLOGICAL FINDINGS IN RELATIVES OF PATIENTS WITH RHEUMATOID ARTHRITIS.

50. BASELINE INFLAMMATORY MARKERS AND DISEASE ACTIVITY INDICES PREDICT TAPERING OF BIOLOGIC AGENTS IN ANKYLOSING SPONDYLITIS.

Catalog

Books, media, physical & digital resources